NEW YORK, June 7 - George Stafford, director of research at Thermo Finnigan, is regarded as one of the great minds behind ion trap mass spectrometry (MS). Back in the early 1980’s he helped to redefine and commercialize the technology, which is today a staple in proteomics research.

Recently, the American Society for Mass Spectrometry recognized Stafford’s contributions, awarding him with their Distinguished Contribution in Mass Spectrometry Award.

To read the full story....

Register for Free.

Already have a GenomeWeb or 360Dx account?
Login Now.

An opinion piece in the Guardian argues that President Donald Trump is uninterested in science and that might not be a bad thing for the field.

The San Francisco Chronicle reports the Veterans Affairs Health System is studying whether genetic testing can help prescribe better depression therapies.

Stat News reports that Spark Therapeutics' Luxturna is now being used to treat a wider array of patients.

In Genome Biology this week: transcription factor use among brittle stars, single-cell RNA sequencing strategy, and more.